[HTML][HTML] Drug efflux pump inhibitors: a promising approach to counter multidrug resistance in Gram-negative pathogens by targeting AcrB protein from AcrAB-TolC …

R Alenazy - Biology, 2022 - mdpi.com
Simple Summary Multidrug-resistant bacterial infections, especially that caused by Gram-
negative bacteria, have posed serious health issues worldwide. Bacteria have different …

Chlorpromazine and amitriptyline are substrates and inhibitors of the AcrB multidrug efflux pump

EM Grimsey, C Fais, RL Marshall, V Ricci, ML Ciusa… - MBio, 2020 - Am Soc Microbiol
Efflux is an important mechanism in Gram-negative bacteria conferring multidrug resistance.
Inhibition of efflux is an encouraging strategy to restore the antibacterial activity of antibiotics …

Molecular basis for inhibition of AcrB multidrug efflux pump by novel and powerful pyranopyridine derivatives

H Sjuts, AV Vargiu, SM Kwasny… - Proceedings of the …, 2016 - National Acad Sciences
The Escherichia coli AcrAB-TolC efflux pump is the archetype of the resistance nodulation
cell division (RND) exporters from Gram-negative bacteria. Overexpression of RND-type …

[HTML][HTML] Ever-adapting RND efflux pumps in gram-negative multidrug-resistant pathogens: a race against time

M Zwama, K Nishino - Antibiotics, 2021 - mdpi.com
The rise in multidrug resistance (MDR) is one of the greatest threats to human health
worldwide. MDR in bacterial pathogens is a major challenge in healthcare, as bacterial …

[HTML][HTML] Bad bugs in the XXIst century: resistance mediated by multi-drug efflux pumps in Gram-negative bacteria

AV Vargiu, KM Pos, K Poole, H Nikaido - Frontiers in microbiology, 2016 - frontiersin.org
The discovery of antibiotics represented a key milestone in the history of medicine. However,
with the rise of these life-saving drugs came the awareness that bacteria deploy defense …

[HTML][HTML] Molecular mechanisms of AcrB-mediated multidrug export

M Zwama, A Yamaguchi - Research in microbiology, 2018 - Elsevier
The over-expression of multidrug efflux pumps belonging to the Resistance-Nodulation-
Division (RND) superfamily is one of the main causes of multidrug-resistance (MDR) in …

Efflux pump inhibitors: a novel approach to combat efflux-mediated drug resistance in bacteria

Y Wang, H Venter, S Ma - Current drug targets, 2016 - ingentaconnect.com
The increasing multi-drug resistance has become a major threat to the public health.
Overexpression of multidrug efflux pumps is one of the major mechanisms of drug resistance …

The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria

XZ Li, P Plésiat, H Nikaido - Clinical microbiology reviews, 2015 - Am Soc Microbiol
The global emergence of multidrug-resistant Gram-negative bacteria is a growing threat to
antibiotic therapy. The chromosomally encoded drug efflux mechanisms that are ubiquitous …

Inhibitors of efflux pumps in Gram-negative bacteria

JM Pagès, M Masi, J Barbe - Trends in molecular medicine, 2005 - cell.com
In Gram-negative bacteria, efflux complexes, consisting of an inner-membrane pump, a
periplasmic adaptor protein and outer-membrane channel, provide an efficient means for the …

Molecular mechanism of MBX2319 inhibition of Escherichia coli AcrB multidrug efflux pump and comparison with other inhibitors

AV Vargiu, P Ruggerone, TJ Opperman… - Antimicrobial agents …, 2014 - Am Soc Microbiol
Efflux pumps of the resistance nodulation division (RND) superfamily, such as AcrB, make a
major contribution to multidrug resistance in Gram-negative bacteria. The development of …